02 October 2025 : Clinical Research
Epidural-Related Fever and Cesarean Delivery: Comparing Ropivacaine/Dexmedetomidine and Ropivacaine/Sufentanil: A Single-Center Randomized Controlled Study in 695 Women
Ying-jie Che BCEF 1, Dan Chen BCE 1, Shayan AmiriDOI: 10.12659/MSM.948993
Med Sci Monit 2025; 31:e948993
Table 3 Indications for intrapartum cesarean section.
| Indications for intrapartum cesarean section | Dex group (n=322) | C group (n=326) | P-value |
|---|---|---|---|
| Total cesarean sections | 82 (25.5) | 82 (25.2) | 0.927 |
| 1. Fetal reasons (no oxytocin) | 11 (3.4) | 6 (1.8) | 0.21 |
| 2. Dys/IUA/ITT/FI | 15 (4.7) | 14 (4.3) | 0.823 |
| 3. Dys/IUA/ITT/OC | 3 (0.9) | 4 (1.2) | 1.0 |
| 4.Dys/IUA/PR | 8 (2.4) | 9 (2.8) | 0.826 |
| 5.Dys/IUA/no oxytocin | 8 (2.4) | 2 (0.6) | 0.107 |
| 6.Dys/EUA/CPD/Mal | 24 (7.5) | 20 (6.1) | 0.505 |
| 7. Maternal request for cesarean section | 10 (3.1) | 10 (3.1) | 0.978 |
| 8. Cesarean section due to epidural analgesia-induced fever | 3 (0.9) | 17 (5.2) | 0.02* |
| Data are presented as number (%). * Dex group – dexmedetomidine group; C group – sufentanil group; Dys – dystocia; IUA – ineffective uterine action; ITT – inability to treat adequately with oxytocin; FI – fetal intolerance; OC – overcontracting; PR – poor response; EUA – effective uterine action; CPD – cephalopelvic disproportion; Mal – malposition. | |||






